Phase II study of pazopanib with weekly paclitaxel in refractory urothelial cancer.

被引:1
|
作者
Srinivas, Sandy
Narayanan, Sujata
Harshman, Lauren Christine
Pachynski, Russell Kent
Lam, Anthony P.
Fan, Alice C.
Poushnejad, Shermeen
Haas, Denise
Vaishampayan, Ulka N.
机构
[1] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[2] Stanford Univ, Stanford, CA 94305 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Washington Univ, Sch Med, St Louis, MO USA
[5] Stanford Canc Inst, Stanford, CA USA
[6] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
关键词
D O I
10.1200/jco.2015.33.7_suppl.294
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
294
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies
    A R Tan
    A Dowlati
    M N Stein
    S F Jones
    J R Infante
    J Bendell
    M P Kane
    K T Levinson
    A B Suttle
    H A Burris III
    British Journal of Cancer, 2014, 110 : 2647 - 2654
  • [42] Phase II Study of Weekly Paclitaxel for Advanced or Metastatic Breast Cancer in Japan
    Horiguchi, Jun
    Rai, Yoshiaki
    Tamura, Kazuo
    Taki, Toshihiko
    Hisamatsu, Kazufumi
    Ito, Yoshinori
    Seriu, Taku
    Tajima, Tomoo
    ANTICANCER RESEARCH, 2009, 29 (02) : 625 - 630
  • [43] PHASE II STUDY OF PAZOPANIB MONOTHERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY UROTHELIAL CANCER ( INT70/09, NCT01031875)
    Necchi, A.
    Nicolai, N.
    Guglielmi, A.
    Bonomi, L.
    Sacco, C.
    Torelli, T.
    Luminari, S.
    Morosi, C.
    Zaffaroni, N.
    Salvioni, R.
    ANNALS OF ONCOLOGY, 2010, 21 : 11 - 11
  • [44] A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.
    Chan, Nancy
    Portal, Daniella E.
    Moss, Rebecca Anne
    Silk, Ann W.
    Stein, Mark N.
    Aisner, Joseph
    Malhotra, Jyoti
    Shih, Weichung
    Lin, Hongxia
    Kane, Michael P.
    Mehnert, Janice M.
    Tan, Antoinette R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] Phase I Study of Pazopanib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumors
    Tan, Antoinette R.
    Dowlati, Afshin
    Jones, Suzanne F.
    Infante, Jeffrey R.
    Nishioka, Jennifer
    Fang, Lei
    Hodge, Jeffrey P.
    Gainer, Shelby D.
    Arumugham, Thangam
    Suttle, A. Benjamin
    Dar, Mohammed M.
    Lager, Joanne J.
    Burris, Howard A., III
    ONCOLOGIST, 2010, 15 (12): : 1253 - 1261
  • [46] Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies
    Tan, A. R.
    Dowlati, A.
    Stein, M. N.
    Jones, S. F.
    Infante, J. R.
    Bendell, J.
    Kane, M. P.
    Levinson, K. T.
    Suttle, A. B.
    Burris, H. A., III
    BRITISH JOURNAL OF CANCER, 2014, 110 (11) : 2647 - 2654
  • [47] A phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer.
    Grecea, D
    Tanasescu, R
    Vasiliniuc, C
    Neamtiu, L
    Ghilezan, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 62S - 62S
  • [48] Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study
    De Lena, M
    Lorusso, V
    Latorre, A
    Fanizza, G
    Gargano, G
    Caporusso, L
    Guida, M
    Catino, A
    Crucitta, E
    Sambiasi, D
    Mazzei, A
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (03) : 364 - 368
  • [49] Phase II study of paclitaxel and cisplatin for metastatic or recurrent esophageal cancer.
    Cho, SH
    Chung, IJ
    Yang, DH
    Byun, JR
    Kim, YK
    Lee, JJ
    Kim, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 326S - 326S
  • [50] MITO-11: A randomized multicenter phase II trial testing the addition of pazopanib to weekly paclitaxel in platinum-resistant or -refractory advanced ovarian cancer (AOC).
    Pignata, Sandro
    Lorusso, Domenica
    Scambia, Giovanni
    Sambataro, Daniela
    Tamberi, Stefano
    Cinieri, Saverio
    Mosconi, Anna Maria
    Orditura, Michele
    Bartolini, Stefania
    Arcangeli, Valentina
    Panici, Pierluigi Benedetti
    Pisano, Carmela
    Cecere, Sabrina Chiara
    Di Napoli, Marilena
    Raspagliesi, Francesco
    Salutari, Vanda
    Daniele, Gennaro
    Piccirillo, Maria Carmela
    Gallo, Ciro
    Perrone, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)